CenExel

CenExel CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and ex*****on of phase I-IV clinical trials.

Our attention to detail assures quality results that both sponsors and patients can trust.


The CenExel Centers of Excellence clinical research network includes ACMR, ACT, AMRI, CBH, CIT, CNR, FCR, JBR, RMCR, RCA, iResearch (locations below). Our Centers of Excellence provide unparalleled medical and scientific support in the design and ex*****on of phase I-IV first-in-human clinical trials. All of our Centers of Excellence have highly experienced Principal Investigator physicians and research staff serving the following indications; Sleep, Pain Management, Dermatology, Movement Disorders, CNS, Vaccines, Womens Services, and Ethnic-Bridging. Our attention to detail assures quality results that both patients and sponsors can trust, which is evident in the consistency that we achieve and exceed our patient recruitment goals. Our patients' wellness and safety are at the heart of every decision we make. We value our sponsor and CRO relationships and are optimistic about the work we will do together in the future as partners. To speak to our business development team email:
marketing@cenexelresearch.com. Visit us at cenexelresearch.com for more information. Where are we located? CenExel HQ: Salt Lake City, UT
ACMR, Atlanta, GA
ACT, Anaheim, CA
AMRI, Toms River, NJ
CBH, Gaithersburg, MD
CIT, Anaheim, CA
CNR, Sherman Oaks, CA
FCR, Tampa, FL
IResearch, Atlanta/Savannah
JBR, SLC, UT
RCA, Hollywood, FL
RMCR, Englewood, CO




Epilepsy is often seen as seizures, but the reality is much more complex.From cognitive challenges to mental health impa...
03/27/2026

Epilepsy is often seen as seizures, but the reality is much more complex.

From cognitive challenges to mental health impacts, many aspects of epilepsy go unseen. And for many people, treatment isn’t one-size-fits-all.

💜 This Purple Day, we’re recognizing the importance of awareness and the need for continued progress.

At CenExel, we support clinical research in neurological conditions and continue to expand opportunities in epilepsy.

Learn more about current and upcoming studies at the link in bio.

American Diabetes Alert Day is a reminder that awareness matters.Nearly half of Americans are living with diabetes or pr...
03/24/2026

American Diabetes Alert Day is a reminder that awareness matters.

Nearly half of Americans are living with diabetes or prediabetes, and many don’t know it. Recognizing the signs early can make a meaningful difference in long-term health outcomes.

At CenExel, we’re committed to advancing clinical research that supports earlier detection, better treatments, and improved disease management.

Because awareness starts the conversation, but research moves care forward.

Learn more about our diabetes clinical trials at the link in bio.

CenExel is heading to Washington, DC for the World Vaccine Congress 2026 🌸Join us March 30 to April 2 at the Walter E. W...
03/23/2026

CenExel is heading to Washington, DC for the World Vaccine Congress 2026 🌸

Join us March 30 to April 2 at the Walter E. Washington Convention Center as we connect with leaders driving innovation across the vaccine landscape.

Attending from CenExel:�
• Linda Wilson, Senior Director, Business Development�
• Lauren White, Director of Business Development�
• Melanie Mestas, Event Manager

We are excited to talk vaccines, clinical strategy, and how CenExel’s sites and operational expertise can help move your program forward with confidence.

If you will be at World Vaccine Congress, let’s schedule time to connect!

CenExel is heading to Florence 🇮🇹 for the 2026 SIRS Annual CongressWe are excited to join the global schizophrenia resea...
03/20/2026

CenExel is heading to Florence 🇮🇹 for the 2026 SIRS Annual Congress

We are excited to join the global schizophrenia research community March 25 to 29 at the Schizophrenia International Research Society meeting. Science, collaboration, and a little bit of Italian sunshine? Yes, please.

Representing CenExel:
• Carol Minoughan, Vice President, Director of Business Development
• Jeanette Caruso, Vice President, Early Phase Business Development
• David Walling, PhD, Chief Scientific Director, CenExel Psychiatry
• Larry Ereshefsky, PharmD, BCPP, Chief Science Officer, CenExel Clinical Sciences

If you are attending SIRS 2026, let’s connect, talk CNS innovation, and explore how we can accelerate your next study.

See you in Florence.

Nothing means more to us than hearing about a great experience from our research participants. ❤️Every volunteer who joi...
03/19/2026

Nothing means more to us than hearing about a great experience from our research participants. ❤️

Every volunteer who joins a clinical trial helps move medicine forward and supports the development of new treatments.

Want to be part of future research opportunities?
Interested in participating in a future study?
👉 Click the link in our bio to sign up for upcoming clinical trials.

Join us this March in recognizing Multiple Sclerosis Awareness Month 🧡Multiple Sclerosis is a chronic neurological condi...
03/18/2026

Join us this March in recognizing Multiple Sclerosis Awareness Month 🧡

Multiple Sclerosis is a chronic neurological condition that affects the central nervous system and can impact each person differently.

Clinical research is essential to advancing scientific understanding and evaluating potential new therapies for MS. At CenExel, our CNS research teams have conducted studies focused on Multiple Sclerosis as part of our commitment to advancing neurological research.

Tap the link in our bio to learn more about MS clinical research opportunities.

Brain Awareness Week highlights the importance of protecting brain health and advancing research to better understand ne...
03/17/2026

Brain Awareness Week highlights the importance of protecting brain health and advancing research to better understand neurological and psychiatric disorders.

At CenExel, our network of clinical research sites conducts studies focused on CNS and brain health, including Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, migraine, and other neurological conditions.

Clinical research plays a critical role in advancing new treatments and improving outcomes for patients.

Learn more about CenExel’s CNS research capabilities at the link in our bio.

CenExel is looking forward to attending the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases ...
03/15/2026

CenExel is looking forward to attending the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases in Copenhagen, Denmark, at the Bella Center Copenhagen, March 17–21, 2026.

Representing our team:
✨ Cecilia Mendez, Psy. D.
✨ Zach Mitchell
✨ Kimball Johnson, MD
✨ Katherine Coerver , M.D., Ph.D., FAAN
✨ Dr. Thomas Shiovitz

We’re excited to connect with sponsors and partners advancing research in neurodegenerative diseases.

If you’ll be attending and would like to schedule a meeting with Dr. Coerver, please reach out to Cecilia Mendez to coordinate.

World Obesity Day was observed on March 4, bringing global attention to the growing impact of obesity and metabolic dise...
03/13/2026

World Obesity Day was observed on March 4, bringing global attention to the growing impact of obesity and metabolic disease.

Obesity is associated with increased risk of serious health conditions including type 2 diabetes, heart disease, stroke, and certain cancers. Continued research is helping advance new treatment approaches that aim to improve long term health outcomes.

At CenExel, our clinical research sites conduct studies focused on obesity and metabolic health, including trials evaluating therapies such as GLP-1 based medications and other emerging treatments.

Clinical trials play an important role in expanding treatment options and improving care.

Interested in participating in obesity research?
Tap the link in our bio to learn more about clinical trials near you.

Today is World Sleep Day and March is Sleep Awareness Month.Sleep is not just about feeling rested. Chronic sleep disrup...
03/13/2026

Today is World Sleep Day and March is Sleep Awareness Month.

Sleep is not just about feeling rested. Chronic sleep disruption is associated with increased risks of high blood pressure, heart disease, stroke, type 2 diabetes, depression, and impaired cognitive performance.

If you experience persistent trouble falling or staying asleep, loud snoring, excessive daytime sleepiness, or difficulty concentrating, it may be time to speak with a healthcare professional.

At CenExel, we are committed to advancing sleep medicine through clinical research. This Sleep Awareness Month, learn how research helps improve understanding and treatment of sleep disorders.

Visit cenexelclinicaltrials.com to stay informed about future sleep research opportunities.

March is National Kidney Month.Kidney disease often progresses silently, making research essential to improving early de...
03/12/2026

March is National Kidney Month.

Kidney disease often progresses silently, making research essential to improving early detection and advancing potential treatment options.

CenExel HRI has experience conducting clinical trials focused on kidney disease and related metabolic conditions. Through collaboration with sponsors and study participants, we support innovation in nephrology research.

To learn more about our research capabilities or future study opportunities, tap the link in our bio.

CenExel is proud to share a newly published peer-reviewed article in the scientific journal Vaccine:“A Phase IIa randomi...
03/11/2026

CenExel is proud to share a newly published peer-reviewed article in the scientific journal Vaccine:

“A Phase IIa randomized clinical trial of a respiratory syncytial virus and human metapneumovirus combination protein-based virus-like particle vaccine in adults 60–85 years of age.”

The randomized, observer-blind clinical trial evaluated safety and immunogenicity in adults ages 60–85 over a 52-week follow-up period.

We recognize Craig Shapiro, DO, Principal Investigator and co-author, and the broader study team for their contribution to this important respiratory research effort.

Read the open access publication at the link in our bio.

Address

13907 Minuteman Drive #150
Draper, UT
84020

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Telephone

+18662363935

Alerts

Be the first to know and let us send you an email when CenExel posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram